Ajanta Pharma Limited is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. The firm offers branded generics and generics that serve a range of therapeutic segments such as antibiotic, anti-malarial, anti-diabetic, cardiology, gynecology, orthopedics, pediatric, respiratory, and general health. It operates through the following geographical segments: India, Africa, Asia, USA, and Others. The company was founded by Purushottam Bhagwand Agrawal in 1973 and is headquartered in Mumbai, India.

ajanta pharma limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Other. ajanta pharma limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE031B01049
Equity Stock (National Stock Exchange) Symbol: AJANTPHARM
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=AJANTPHARM
BSE Link IS: https://www.bseindia.com/stock-share-price/ajanta-pharma-ltd/AJANTPHARM/532331/

Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70)

India – Branded Generic business (30% of revenues) Focused on niche and first-to-market drugs in 4 therapeutic areas – cardiology, ophthalmology, dermatology, pain management

Ajanta Pharma Limited (APL) is a pharmaceutical company headquartered in Mumbai, India. It has strong presence in Branded Generic business in India & Emerging markets; and Generic business in USA.

In India, company operates in selected therapeutic areas of Cardiology, Dermatology, Ophthalmology and Pain management. It’s brands hold leadership positions in sub-therapeutic areas they are present in.

In Emerging Markets, company has presences in Africa, South East Asia, West Asia, and CIS on broader therapeutic segments such as anti-malarial, gastro, antibiotics, cardiology, dermatology, pain management, etc.

As on 31 March 2021, Ajanta has 36 ANDA approvals which are commercialised. And it is awaiting US FDA approval for 15 ANDAs. Company plans to file 10-12 ANDAs during the current financial year.

Company has state-of-the-art research facilities for formulation and API development located at Mumbai, India. R&D capabilities are evident from number of 1st to market products launched by the company providing patients most needed compliance and convenience. A dedicated and focused team of over 650+ scientists work for R&D, which is growing continuously.

Ajanta has 6 formulations manufacturing facilities located in India and 1 in Mauritius. Besides that, it also has an API manufacturing facility located at Waluj, India. Ajanta’s flagship formulation facilities at Paithan (Maharashtra, India) and Dahej (Gujarat, India) have been approved by US FDA.

Ajanta continuously invests in enhancing the existing manufacturing facilities to meet current cGMP requirements and also construct new facilities to meet company’s growth requirements.

Please visit http://ajantapharma.com/ for more information.

Ajanta Pharma Ltd stand with [Serving Health Care Needs Worldwide]

Company Website: http://www.ajantapharma.com/
Company Website2: http://www.ajantapharma.com/
LinkedIn page URL: https://in.linkedin.com/company/ajanta-pharma-ltd
Wiki Profile URL: https://en.wikipedia.org/wiki/Ajanta_Pharma

Popular Search Keywords: ajanta pharma limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Other industry

#ajanta #pharma #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #other #industry

The post Ajanta Pharma Limited Company Profile | KooCapital.Com appeared first on KooCapital.Com.